Professor Peter Frith, from Flinders University, told the Respiratory Insights Forum that dual therapy with a LABA/LAMA combination exceeds the benefits of monotherapy on all clinically important outcome measures for patients with moderate to severe COPD1. Their use was supported by both GOLD1 and COPD-X2 guidelines as part of the stepwise management of COPD. “For ...
LABA/LAMA combo holds its place in COPD management
Sponsored by A. Menarini Pty Ltd
2 Nov 2017